These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 11361485

  • 21. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up.
    Resino S, Resino R, Micheloud D, Gurbindo Gutiérrez D, Léon JA, Ramos JT, Ciria L, de José I, Mellado J, Muñoz-Fernández A, Spanish Group of Paediatric HIV Infection.
    Clin Infect Dis; 2006 Mar 15; 42(6):862-9. PubMed ID: 16477566
    [Abstract] [Full Text] [Related]

  • 22. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era.
    Madeddu G, Porqueddu EM, Cambosu F, Saba F, Fois AG, Pirina P, Mura MS.
    Infection; 2008 Jun 15; 36(3):231-6. PubMed ID: 18463787
    [Abstract] [Full Text] [Related]

  • 23. Treatment interruption for virological failure or as sparing regimen in children with chronic HIV-1 infection.
    Monpoux F, Tricoire J, Lalande M, Reliquet V, Bebin B, Thuret I.
    AIDS; 2004 Dec 03; 18(18):2401-9. PubMed ID: 15622316
    [Abstract] [Full Text] [Related]

  • 24. Outcomes of human immunodeficiency virus-infected and -exposed children undergoing surgery--a prospective study.
    Karpelowsky JS, Leva E, Kelley B, Numanoglu A, Rode H, Millar AJ.
    J Pediatr Surg; 2009 Apr 03; 44(4):681-7. PubMed ID: 19361626
    [Abstract] [Full Text] [Related]

  • 25. Prevalence and risk factors associated with antiretroviral resistance in HIV-1-infected children.
    Delaugerre C, Warszawski J, Chaix ML, Veber F, Macassa E, Buseyne F, Rouzioux C, Blanche S.
    J Med Virol; 2007 Sep 03; 79(9):1261-9. PubMed ID: 17607781
    [Abstract] [Full Text] [Related]

  • 26. Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: implications for routine resistance screening before initiation of antiretroviral therapy.
    Novak RM, Chen L, MacArthur RD, Baxter JD, Huppler Hullsiek K, Peng G, Xiang Y, Henely C, Schmetter B, Uy J, van den Berg-Wolf M, Kozal M, Terry Beirn Community Programs for Clinical Research on AIDS 058 Study Team.
    Clin Infect Dis; 2005 Feb 01; 40(3):468-74. PubMed ID: 15668873
    [Abstract] [Full Text] [Related]

  • 27. Characterization of GBV-C infection in HIV-1 infected patients.
    Canducci F, Uberti Foppa C, Boeri E, Racca S, Gallotta G, Grasso MA, Calori G, Lazzarin A, Clementi M.
    J Biol Regul Homeost Agents; 2003 Feb 01; 17(2):191-4. PubMed ID: 14518722
    [Abstract] [Full Text] [Related]

  • 28. The prevalence and risk of hepatitis flares in a Serbian cohort of HIV and HCV co-infected patients treated with HAART.
    Jevtović Dj, Ranin J, Salemović D, Pesić I, Dragović G, Zerjav S, Djurković-Djaković O.
    Biomed Pharmacother; 2008 Jan 01; 62(1):21-5. PubMed ID: 17223307
    [Abstract] [Full Text] [Related]

  • 29. Mutations linked to drug resistance, human immunodeficiency virus type 1 biologic phenotype and their association with disease progression in children receiving nucleoside reverse transcriptase inhibitors.
    Englund JA, Raskino C, Vavro C, Palumbo P, Ross LL, McKinney R, Nikolic-Djokic D, Colgrove RC, Baker CJ, Pediatric AIDS Clinical Trials Group Protocol 152 Team.
    Pediatr Infect Dis J; 2004 Jan 01; 23(1):15-22. PubMed ID: 14743040
    [Abstract] [Full Text] [Related]

  • 30. Neurocognitive functioning in pediatric human immunodeficiency virus infection: effects of combined therapy.
    Shanbhag MC, Rutstein RM, Zaoutis T, Zhao H, Chao D, Radcliffe J.
    Arch Pediatr Adolesc Med; 2005 Jul 01; 159(7):651-6. PubMed ID: 15996999
    [Abstract] [Full Text] [Related]

  • 31. Varicella zoster as a manifestation of immune restoration disease in HIV-infected children.
    Tangsinmankong N, Kamchaisatian W, Lujan-Zilbermann J, Brown CL, Sleasman JW, Emmanuel PJ.
    J Allergy Clin Immunol; 2004 Apr 01; 113(4):742-6. PubMed ID: 15100682
    [Abstract] [Full Text] [Related]

  • 32. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa.
    Reddi A, Leeper SC, Grobler AC, Geddes R, France KH, Dorse GL, Vlok WJ, Mntambo M, Thomas M, Nixon K, Holst HL, Karim QA, Rollins NC, Coovadia HM, Giddy J.
    BMC Pediatr; 2007 Mar 17; 7():13. PubMed ID: 17367540
    [Abstract] [Full Text] [Related]

  • 33. Hospital-based directly observed therapy for HIV-infected children and adolescents to assess adherence to antiretroviral medications.
    Glikman D, Walsh L, Valkenburg J, Mangat PD, Marcinak JF.
    Pediatrics; 2007 May 17; 119(5):e1142-8. PubMed ID: 17452493
    [Abstract] [Full Text] [Related]

  • 34. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro.
    Jevtović DO, Salemović D, Ranin J, Pesić I, Zerjav S, Djurković-Djaković O.
    HIV Med; 2007 Mar 17; 8(2):75-9. PubMed ID: 17352762
    [Abstract] [Full Text] [Related]

  • 35. HIV infection/acquired immunodeficiency syndrome at Siriraj Hospital, 2002: time for secondary prevention.
    Anekthananon T, Ratanasuwan W, Techasathit W, Rongrungruang Y, Suwanagool S.
    J Med Assoc Thai; 2004 Feb 17; 87(2):173-9. PubMed ID: 15061301
    [Abstract] [Full Text] [Related]

  • 36. Otitis media in Brazilian human immunodeficiency virus infected children undergoing antiretroviral therapy.
    Miziara ID, Weber R, Araújo Filho BC, Pinheiro Neto CD.
    J Laryngol Otol; 2007 Nov 17; 121(11):1048-54. PubMed ID: 17319998
    [Abstract] [Full Text] [Related]

  • 37. Prevalence of proteinuria among HIV-infected children attending a tertiary hospital in Lagos, Nigeria.
    Esezobor CI, Iroha E, Onifade E, Akinsulie AO, Temiye EO, Ezeaka C.
    J Trop Pediatr; 2010 Jun 17; 56(3):187-90. PubMed ID: 19793893
    [Abstract] [Full Text] [Related]

  • 38. Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study.
    Sogaard OS, Lohse N, Gerstoft J, Kronborg G, Ostergaard L, Pedersen C, Pedersen G, Sørensen HT, Obel N.
    Clin Infect Dis; 2008 Nov 15; 47(10):1345-53. PubMed ID: 18834317
    [Abstract] [Full Text] [Related]

  • 39. Prevalence of anemia and correlation with biomarkers and specific antiretroviral regimens in 9690 human-immunodeficiency-virus-infected patients: findings of the Anemia Prevalence Study.
    Mildvan D, Creagh T, Leitz G, Anemia Prevalence Study Group.
    Curr Med Res Opin; 2007 Feb 15; 23(2):343-55. PubMed ID: 17288689
    [Abstract] [Full Text] [Related]

  • 40. Team management of failure to thrive.
    Peterson KE, Washington J, Rathbun JM.
    J Am Diet Assoc; 1984 Jul 15; 84(7):810-5. PubMed ID: 6736509
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.